Found: 2298
Select item for more details and to access through your institution.
Searching for an Elusive Phantom – Targeting Estrogen in Pulmonary Hypertension.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 12, p. 1229, doi. 10.1177/10600280241241531
- By:
- Publication type:
- Article
Similar fatty acid status of plasma lipids in postmenopausal women newly diagnosed with breast cancer and those receiving aromatase inhibitor therapy.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2021, v. 78, n. 11, p. 1140, doi. 10.2298/VSP200124032K
- By:
- Publication type:
- Article
The role of trust in the acceptance of adjuvant endocrine therapy in breast cancer patients.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 12, p. 2122, doi. 10.1002/pon.6049
- By:
- Publication type:
- Article
Abstracts of the American Psychosocial Oncology Society Annual Virtual Conference, 10-12 March 2021.
- Published in:
- 2021
- Publication type:
- Journal Article
Hybrid machine learning‐based breast cancer segmentation framework using ultrasound images with optimal weighted features.
- Published in:
- Cell Biochemistry & Function, 2024, v. 42, n. 4, p. 1, doi. 10.1002/cbf.4054
- By:
- Publication type:
- Article
Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Therapy delay due to COVID-19 pandemic among European women with breast cancer: prevalence and associated factors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 11749, doi. 10.1007/s00432-023-05065-7
- By:
- Publication type:
- Article
Breast cancer therapy in women under 35 years and between 50 and 69 years: influence of the observation period.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5665, doi. 10.1007/s00432-022-04520-1
- By:
- Publication type:
- Article
Low TINAGL1 expression is a marker for poor prognosis in breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4771, doi. 10.1007/s00432-022-04394-3
- By:
- Publication type:
- Article
Tumor characteristics, therapy, and prognosis in young breast cancer patients ≤ 35 years.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 709, doi. 10.1007/s00432-022-04374-7
- By:
- Publication type:
- Article
Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 3, p. 719, doi. 10.1007/s00432-021-03651-1
- By:
- Publication type:
- Article
Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 6, p. 1833, doi. 10.1007/s00432-020-03472-8
- By:
- Publication type:
- Article
Conditional knockdown of integrin beta-3 reveals its involvement in osteolytic and soft tissue lesions of breast cancer skeletal metastasis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 2, p. 361, doi. 10.1007/s00432-020-03428-y
- By:
- Publication type:
- Article
Breast cancer: are long-term and intermittent endocrine therapies equally effective?
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 8, p. 2041, doi. 10.1007/s00432-020-03264-0
- By:
- Publication type:
- Article
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 6, p. 1559, doi. 10.1007/s00432-020-03184-z
- By:
- Publication type:
- Article
Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Breast cancer: evaluating the axilla before, during, and after therapy—new challenges.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models.
- Published in:
- European Radiology, 2024, v. 34, n. 4, p. 2546, doi. 10.1007/s00330-023-10198-x
- By:
- Publication type:
- Article
Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
- Published in:
- European Radiology, 2023, v. 33, n. 4, p. 2965, doi. 10.1007/s00330-022-09264-7
- By:
- Publication type:
- Article
Muscle mass loss after neoadjuvant chemotherapy in breast cancer: estimation on breast magnetic resonance imaging using pectoralis muscle area.
- Published in:
- European Radiology, 2020, v. 30, n. 8, p. 4234, doi. 10.1007/s00330-020-06799-5
- By:
- Publication type:
- Article
Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
- Published in:
- European Radiology, 2020, v. 30, n. 1, p. 57, doi. 10.1007/s00330-019-06365-8
- By:
- Publication type:
- Article
Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Magnetic resonance imaging texture analysis classification of primary breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of Safety and Treatment Continuity of Palbociclib and Abemaciclib for Hormone Receptor-Positive, HER2-Negative Metastatic/Recurrent Breast Cancer.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 6, p. 1258, doi. 10.1177/08971900241247653
- By:
- Publication type:
- Article
MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 48, n. 2, p. 461, doi. 10.1159/000491777
- By:
- Publication type:
- Article
Antiestrogenic Activity of the Xi-Huang Formula for Breast Cancer by Targeting the Estrogen Receptor α.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 47, n. 6, p. 2199, doi. 10.1159/000491533
- By:
- Publication type:
- Article
Is Clinical Risk Score a Useful Predictive Marker of Early Recurrence Among Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors?
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 2, p. 106, doi. 10.14744/ejmi.2024.52208
- By:
- Publication type:
- Article
Correlation of HALP Score and Menopause Status with Treatment Response in Hormone Receptor-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 2, p. 137, doi. 10.14744/ejmi.2024.49044
- By:
- Publication type:
- Article
Overcoming Hormone Resistance in Breast Cancer Cell Lines: The Impact of Combined Treatment with Sorafenib and Palbociclib on Cell Survival and Proliferation Pathways.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 1, p. 13, doi. 10.14744/ejmi.2023.14963
- By:
- Publication type:
- Article
Effect of Inflammatory Markers on the Pathologic Complete Response in the Neoadjuvan Treatment of HER-2 Positive Local Advanced Breast Cancer.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 417, doi. 10.14744/ejmi.2022.65683
- By:
- Publication type:
- Article
Absence of Germline BRCA1 c.68_69delAG and c.5266dupC Mutations among Hormone Receptor-negative Breast Cancer Patients: A First Impression at a Tertiary Cancer-care Facility in Tanzania.
- Published in:
- Tanzania Journal of Science, 2021, v. 47, n. 5, p. 1824, doi. 10.4314/tjs.v47i5.27
- By:
- Publication type:
- Article
Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0098-1
- By:
- Publication type:
- Article
Epidemiological Study of CA Breast in Diyala.
- Published in:
- Diyala Journal of Medicine, 2022, v. 22, n. 2, p. 8, doi. 10.26505/DJM.22026190823
- By:
- Publication type:
- Article
Ribociclib Plus Endocrine Therapy Improves Invasive Disease-Free Survival in Patients With HR-Positive, HER2-Negative, Early Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 4, p. 7
- By:
- Publication type:
- Article
Trodelvy Now Approved for Pretreated Patients with HR-Positive, HER2-Negative Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 2, p. 14
- Publication type:
- Article
Imbruvica Now Approved for Treatment of Pediatric Patients with Chronic GVHD, Including New Oral Suspension Formulation.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 5, p. 13
- Publication type:
- Article
Yescarta First CAR T-Cell Therapy FDA Approved for Patients with Large B-Cell Lymphoma.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 3, p. 11
- Publication type:
- Article
Elacestrant Yields Positive Outcomes in Patients with ER-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 2, p. 20
- By:
- Publication type:
- Article
Lynparza Receives FDA Approval for Adjuvant Treatment of High-Risk Early Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 2, p. 12
- Publication type:
- Article
Keytruda Monotherapy FDA Approved for Endometrial Carcinoma with a Biomarker.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 2, p. 11
- Publication type:
- Article
Tecentriq Approved for Adjuvant Treatment of Patients with Early-Stage NSCLC and PD-L1 Expression.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 6, p. 9
- Publication type:
- Article
NEW INDICATIONS.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 3, p. 17
- Publication type:
- Article
FDA NEWS.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 7
- Publication type:
- Article
Enfortumab Vedotin Extends Survival in Metastatic Urothelial Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
Abemaciclib Added to Endocrine Therapy Reduces Invasive Disease Recurrence in High-Risk HR-Positive Early Breast Cancer: monarchE.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
Bemarituzumab, FGFR2b Inhibitor, Improves Survival in Advanced Gastric Cancer with FGFR2b Mutation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article